Survivin as a prognostic factor for osteosarcoma patients

Acta Histochemica et Cytochemica

Volumn 39, Issue 3, 2006, Pages 95-100

  Osaka, Eiji ^a   Suzuki, Takashi ^a,b   Osaka, Shunzo ^a   Yoshida, Yukihiro ^a   Sugita, Hideyuki ^a   Asami, Satoru ^b   Tabata, Keiichi ^b   Hemmi, Akihiro ^a   Sugitani, Masahiko ^a   Nemoto, Norimichi ^a   Ryu, Junnosuke ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Osteosarcoma; Paraffin embedded tissue; Prognostic factor; Survivin

Indexed keywords

APOPTOSIS INHIBITOR; BIOLOGICAL FACTOR; GLYSERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OXIDOREDUCTASE; PARAFFIN; RNA; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; OSTEOSARCOMA; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 33745700083     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.06005     Document Type: Article

References (27)

1. Abrahamsen, H. N., Steiniche, T., Nexo, E., Hamilton-Dutoit, S. J. and Sorensen, B. S. (2003) Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients. J. Mol. Diagn. 5; 34-41.
2. Adams, V., Hany, M. A., Schmid, M., Hassam, S., Briner, J. and Niggli, F. K. (1996) Detection of t(11;22)(q24;q12) translocation breakpoint in paraffin-embedded tissue of the Ewing's sarcoma family by nested reverse transcription-polymerase chain reaction. Diagn. Mol. Pathol. 5; 107-113.
3. Ambrosini, G., Adida, C. and Altieri, D. C. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3; 917-921.
4. Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., Zoubek, A., Jurgens, H. and Winkler, K. (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 20; 776-790.
5. Chiou, S. K., Jones, M. K. and Tarnawski, A. S. (2003) Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med. Sci. Monit. 9; PI25-29.
6. Cohen, G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326; 1-16.
7. Dorsey, B. V., Benjamin, L. E., Rauscher F, 3rd., Klencke, B., Venook, A. P., Warren, R. S. and Weidner, N. (1996) Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile. Mod. Pathol. 9; 703-709.
8. Edwards, R. H., Chatten, J., Xiong, Q. B. and Barr, F. G. (1997) Detection of gene fusions in rhabdomyosarcoma by reverse transcriptase- polymerase chain reaction assay of archival samples. Diagn. Mol. Pathol. 6; 91-97.
9. Enneking, W. F., Spanier, S. S. and Goodman, M. A. (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin. Orthop. Relat. Res. 153; 106-120.
10. Finke, J., Fritzen, R., Ternes, P., Lange, W. and Dolken, G. (1993) An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques 14; 448-453.
11. Hisaoka, M., Tsuji, S., Morimitsu, Y., Hashimoto, H., Shimajiri, S., Komiya, S. and Ushijima, M. (1998) Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Diagn. Mol. Pathol. 7; 96-101.
12. Islam, A., Kageyama, H., Takada, N., Kawamoto, T., Takayasu, H., Isogai, E., Ohira, M., Hashizume, K., Kobayashi, H., Kaneko, Y. and Nakagawara, A. (2000) High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19; 617-623.
13. Kami, K., Doi, R., Koizumi, M., Toyoda, E., Mori, T., Ito, D., Fujimoto, K., Wada, M., Miyatake, S. and Imamura, M. (2004) Survivin expression in a prognostic marker in pancreatic cancer patients. Surgery 136; 443-448.
14. Kappler, M., Kohler, T., Kampf, C., Diestelkotter, P., Wurl, P., Schmitz, M., Bartel, F., Lautenschlager, C., Rieber, E. P., Schmidt, H., Bache, M., Taubert, H. and Meye, A. (2001) Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int. J. Cancer 95; 360-363.
15. Meng, H., Lu, C. D., Sun, Y. L., Dai, D. J., Lee, S. W. and Tanigawa, N. (2004) Expression level of wild-type survivin in gastric cancer is an independent predictor of survival. World J. Gastroenterol. 10; 3245-3250.
16. Miyachi, K., Sasaki, K., Onodera, S., Taguchi, T., Nagamachi, M., Kaneko, H. and Sunagawa, M. (2003) Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer 6; 217-224.
17. Monzo, M., Rosell, R., Felip, E., Astudillo, J., Sanchez, J. J., Maestre, J., Martin, C., Font, A., Barnadas, A. and Abad, A. (1999) A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 17; 2100-2104.
18. Park, Y. K., Chi, S. G., Park, H. R., Yang, M. H. and Unni, K. K. (1998) Detection of t(11;22)(q24;q12) translocation of Ewing's sarcoma in paraffin embedded tissue by nested reverse transcription-polymerase chain reaction. J. Korean Med. Sci. 13; 395-399.
19. Rosen, G. and Nirenberg, A. (1985) Neoadjuvant chemotherapy for osteogenic sarcoma: a five year follow-up (T-10) and preliminary report of new studies (T-12). Prog. Clin. Biol. Res. 201; 39-51.
20. Sarela, A. I., Macadam, R. C., Farmery, S. M., Markham, A. F. and Guillou, P. J. (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46; 645-650.
21. Span, P. N., Sweep, F. C., Wiegerinck, E. T., Tjan-Heijnen, V. C., Manders, P., Beex, L. V. and de Kok, J. B. (2004) Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin. Chem. 50; 1986-1993.
22. Stanta, G. and Schneider, C. (1991) RNA extracted from paraffin-embedded human tissues is amenable to analysis by PCR amplification. Biotechniques 11; 304, 306, 308.
23. Takenaka, M., Imamura, T., Nojima, T. and Takegami, T. (2001) Extraction of RNA from paraffin embedded tissues and analysis of p53 gene expression in colonic cancer. Rinsho Byori 49; 278-282.
24. Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Vigna, N., Oltersdorf, T. and Reed, J. C. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases and anticancer drugs. Cancer Res. 58; 5315-5320.
25. Trieb, K., Lehner, R., Stulnig, T., Sulzbacher, I. and Shroyer, K. R. (2003) Survivin expression in human osteosarcoma is a marker for survival. Eur. J. Surg. Oncol. 29; 379-382.
26. Tsuji, S., Hisaoka, M., Morimitsu, Y., Hashimoto, H., Shimajiri, S., Komiya, S., Ushijima, M. and Nakamura, T. (1998) Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am. J. Pathol. 153; 1807-1812.
27. Wang, H., Xi, X., Kong, X., Huang, G. and Ge, G. (2004) The expression and significance of survivin mRNA in urinary bladder carcinomas. J. Cancer Res. Clin. Oncol. 130; 487-490.